Taurine mitigates cirrhosis-associated heart injury through mitochondrial-dependent and antioxidative mechanisms
- PMID: 33145427
- PMCID: PMC7592093
- DOI: 10.5114/ceh.2020.99513
Taurine mitigates cirrhosis-associated heart injury through mitochondrial-dependent and antioxidative mechanisms
Abstract
Cirrhosis-induced heart injury and cardiomyopathy is a serious consequence of this disease. It has been shown that bile duct ligated (BDL) animals could serve as an appropriate experimental model to investigate heart tissue injury in cirrhosis. The accumulation of cytotoxic chemicals (e.g., bile acids) could also adversely affect the heart tissue. Oxidative stress and mitochondrial impairment are the most prominent mechanisms of bile acid cytotoxicity. Taurine (Tau) is the most abundant non-protein amino acid in the human body. The cardioprotective effects of this amino acid have repeatedly been investigated. In the current study, it was examined whether mitochondrial dysfunction and oxidative stress are involved in the pathogenesis of cirrhosis-induced heart injury. Rats underwent BDL surgery. BDL animals received Tau (50, 100, and 500 mg/kg, i.p.) for 42 consecutive days. A significant increase in oxidative stress biomarkers was detected in the heart tissue of BDL animals. Moreover, it was found that heart tissue mitochondrial indices of functionality were deteriorated in the BDL group. Tau treatment significantly decreased oxidative stress and improved mitochondrial function in the heart tissue of cirrhotic animals. These data provide clues for the involvement of mitochondrial impairment and oxidative stress in the pathogenesis of heart injury in BDL rats. On the other hand, Tau supplementation could serve as an effective ancillary treatment against BDL-associated heart injury. Mitochondrial regulating and antioxidative properties of Tau might play a fundamental role in its mechanism of protective effects in the heart tissue of BDL animals.
Keywords: amino acid; bioenergetics; cardiomyopathy; cirrhosis; heart failure; mitochondrial impairment.
Copyright © 2020 Clinical and Experimental Hepatology.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Cellular and mitochondrial taurine depletion in bile duct ligated rats: a justification for taurine supplementation in cholestasis/cirrhosis.Clin Exp Hepatol. 2022 Sep;8(3):195-210. doi: 10.5114/ceh.2022.119216. Epub 2022 Sep 21. Clin Exp Hepatol. 2022. PMID: 36685263 Free PMC article.
-
Taurine mitigates the development of pulmonary inflammation, oxidative stress, and histopathological alterations in a rat model of bile duct ligation.Naunyn Schmiedebergs Arch Pharmacol. 2022 Dec;395(12):1557-1572. doi: 10.1007/s00210-022-02291-7. Epub 2022 Sep 13. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 36097067
-
Taurine mitigates bile duct obstruction-associated cholemic nephropathy: effect on oxidative stress and mitochondrial parameters.Clin Exp Hepatol. 2021 Mar;7(1):30-40. doi: 10.5114/ceh.2021.104675. Epub 2021 Mar 25. Clin Exp Hepatol. 2021. PMID: 34027113 Free PMC article.
-
Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice.Biomed Pharmacother. 2018 Jan;97:1086-1095. doi: 10.1016/j.biopha.2017.10.166. Epub 2017 Nov 10. Biomed Pharmacother. 2018. PMID: 29136945
-
Taurine supplementation abates cirrhosis-associated locomotor dysfunction.Clin Exp Hepatol. 2018 Jun;4(2):72-82. doi: 10.5114/ceh.2018.75956. Epub 2018 May 25. Clin Exp Hepatol. 2018. PMID: 29904723 Free PMC article.
Cited by
-
Cellular and mitochondrial taurine depletion in bile duct ligated rats: a justification for taurine supplementation in cholestasis/cirrhosis.Clin Exp Hepatol. 2022 Sep;8(3):195-210. doi: 10.5114/ceh.2022.119216. Epub 2022 Sep 21. Clin Exp Hepatol. 2022. PMID: 36685263 Free PMC article.
-
The Protective Effects of Taurine, a Non-essential Amino Acid, Against Metals Toxicities: A Review Article.Biol Trace Elem Res. 2025 Feb;203(2):872-890. doi: 10.1007/s12011-024-04191-8. Epub 2024 May 13. Biol Trace Elem Res. 2025. PMID: 38735894 Review.
-
Cardioprotection and neurobehavioral impact of swimming training in ovariectomized rats.Geroscience. 2025 Apr;47(2):2317-2334. doi: 10.1007/s11357-024-01422-7. Epub 2024 Nov 11. Geroscience. 2025. PMID: 39527177 Free PMC article.
-
Pulmonary inflammation, oxidative stress, and fibrosis in a mouse model of cholestasis: the potential protective properties of the dipeptide carnosine.Naunyn Schmiedebergs Arch Pharmacol. 2023 Jun;396(6):1129-1142. doi: 10.1007/s00210-023-02391-y. Epub 2023 Jan 18. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36651945
-
The Role of Mitochondrial Impairment and Oxidative Stress in the Pathogenesis of Lithium-Induced Reproductive Toxicity in Male Mice.Front Vet Sci. 2021 Mar 24;8:603262. doi: 10.3389/fvets.2021.603262. eCollection 2021. Front Vet Sci. 2021. PMID: 33842567 Free PMC article.
References
-
- Milani A, Zaccaria R, Bombardieri G, et al. . Cirrhotic cardiomyopathy. Dig Liver Dis 2007; 39: 507-515. - PubMed
-
- Zardi EM, Abbate A, Zardi DM, et al. . Cirrhotic cardiomyopathy. J Am Coll Cardiol 2010; 56: 539-549. - PubMed
-
- Wiese S, Hove JD, Bendtsen F, Møller S. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2014; 11: 177-186. - PubMed
-
- Møller S, Hove JD, Dixen U, Bendtsen F. New insights into cirrhotic cardiomyopathy. Int J Cardiol 2013; 167: 1101-1108. - PubMed
-
- Gaskari SA, Honar H, Lee SS. Therapy insight: Cirrhotic cardiomyopathy. Gastroenterol Hepatol (N Y) 2006; 3: 329-337. - PubMed
LinkOut - more resources
Full Text Sources